Gerard J. Criner, MD
Potential Financial Conflicts of Interest: Consultancies: Ortho Biotech, Schering-Plough, Boehringer Ingelheim, Actelion, Shire Pharmaceuticals, Sepracor Pharmaceuticals; Honoraria: Ortho Biotech, Schering-Plough, Boehringer Ingelheim, Actelion, Shire Pharmaceuticals, Sepracor Pharmaceuticals; Grants received: Schering-Plough, Boehringer Ingelheim, Actelion, GlaxoSmithKline, Altana Pharma, Daiichi Asubio Pharmaceuticals, Pfizer Inc., Roche Pharmaceuticals, Sepracor Pharmaceuticals, Emphasys Medical Inc., Aeris Therapeutics Inc.; Grants pending: Boehringer Ingelheim, GlaxoSmithKline.
Requests for Single Reprints: Gerard J. Criner, MD, Pulmonary and Critical Care Medicine and Temple Lung Center, Temple University School of Medicine, 745 Parkinson Pavilion, 3401 North Broad Street, Philadelphia, PA 19140; e-mail, email@example.com.
Criner GJ. Optimal Treatment of Chronic Obstructive Pulmonary Disease: The Search for the Magic Combination of Inhaled Bronchodilators and Corticosteroids. Ann Intern Med. ;146:606–608. doi: 10.7326/0003-4819-146-8-200704170-00012
Download citation file:
Published: Ann Intern Med. 2007;146(8):606-608.
Chronic Obstructive Airway Disease, Endocrine and Metabolism, Pulmonary/Critical Care.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use